Exact Mass: 384.281

Ibutilide

C20H36N2O3S (384.2447)

Ibutilide is only found in individuals that have used or taken this drug. It is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. [Wikipedia]Ibutilide is a pure class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular level it exerts two main actions: induction of a persistent Na+ current sensitive to dihydropyridine Ca²⁺ channel blockers and potent inhibition of the cardiac rapid delayed rectifier K⁺ current, by binding within potassium channel pores. In other words, Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker

8,11,14,17,20,23-hexacosahexaenoic acid

C26H40O2 (384.3028)

Tetrahydropersin

C23H44O4 (384.3239)

Tetrahydropersin is found in fruits. Tetrahydropersin is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Tetrahydropersin is found in fruits.

Persicaxanthin

C25H36O3 (384.2664)

Persicaxanthin is found in european plum. Persicaxanthin is isolated from plums Prunus domestic Isolated from plums Prunus domestica. Persicaxanthin is found in fruits and european plum.

(-)-Pyrifolidine

C23H32N2O3 (384.2413)

(-)-Pyrifolidine is an alkaloid from Aspidosperma quebracho-blanco (quebracho). Alkaloid from Aspidosperma quebracho-blanco (quebracho).

Persicachrome

C25H36O3 (384.2664)

(3S,5R,8S)-Persicachrome is found in fruits. (3S,5R,8S)-Persicachrome is a constituent of flesh of cling peaches (Prunus persica). Constituent of flesh of cling peaches (Prunus persica). (3S,5R,8S)-Persicachrome is found in fruits.

MG(0:0/20:1(11Z)/0:0)

C23H44O4 (384.3239)

MG(0:0/20:1(11Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.

MG(20:1(11Z)/0:0/0:0)

C23H44O4 (384.3239)

MG(20:1(11Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.

N-Palmitoyl Glutamine

C21H40N2O4 (384.2988)

N-palmitoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

N-Myristoyl Arginine

C20H40N4O3 (384.31)

N-myristoyl arginine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Arginine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Arginine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Arginine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

16-Nitroxystearate

C22H42NO4 (384.3114)

4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene

C22H32N4O2 (384.2525)

Estradiol enanthate

C25H36O3 (384.2664)

(Z)-3-(1,2-Dihydroxyethyl)-3-hydroxyhenicos-12-en-2-one

C23H44O4 (384.3239)

Zipeprol

C23H32N2O3 (384.2413)

R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

Surinone B

C25H36O3 (384.2664)

Epipolasinthiourea B

C24H36N2S (384.2599)

Betaenone D

C21H36O6 (384.2512)

Isodehydroluffariellolide

C25H36O3 (384.2664)

Variecolactone

C25H36O3 (384.2664)

Palauolide

C25H36O3 (384.2664)

Calicoferol H

C26H40O2 (384.3028)

Epipolasinthiourea A

C24H36N2S (384.2599)

25-Hydroxy-13(24),15,17-cheilanthatrien-18,25-olide

C25H36O3 (384.2664)

Sinuflexibilin

C21H36O6 (384.2512)

Mdmb-chmica, ()-

C23H32N2O3 (384.2413)

CHEBI:143755

C21H36O6 (384.2512)

GNF-Pf-5086

C23H32N2O3 (384.2413)

MMV687730

C22H32N4O2 (384.2525)

debilisone D

C25H36O3 (384.2664)

(1E,4S,5E,7R)-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene

C21H36O6 (384.2512)

N-Methyl-N-(2,3,11a-trimethyl-2,3,3a,4,5,5a,5b,6,8,9,10,11,11a,11b,12,13-hexadecahydro-1H-2-aza-pentaleno[1,6a-a]phenanthren-9-yl)-acetamide

C25H40N2O (384.314)

Arctigenin

C21H36O6 (384.2512)

Arvoside A

C21H36O6 (384.2512)

luffarin-N

C25H36O3 (384.2664)

luffarin-H

C25H36O3 (384.2664)

Leucylarginylproline

C17H32N6O4 (384.2485)

Aspidolimine

C23H32N2O3 (384.2413)

coscinalactone

C25H36O3 (384.2664)

12-O-desacetylfuroscalar-16-one

C25H36O3 (384.2664)

salmahyrtisol B

C25H36O3 (384.2664)

Vincaminoridine

C23H32N2O3 (384.2413)

C25H36O3

C25H36O3 (384.2664)

C26H40O2

C26H40O2 (384.3028)

(3beta,22E)-3-Hydroxy-24-norcholesta-5,22-dien-7-one

C26H40O2 (384.3028)

Aplysolide A

C25H36O3 (384.2664)

5alpha,6alpha-epoxy-26,27-dinorergosta-7,22(E)-dien-3beta-ol

C26H40O2 (384.3028)

Loroxanthin

C25H36O3 (384.2664)

5,6-Dideoxy-5-oxo-erythronolid B

C21H36O6 (384.2512)

6-epi-ophiobolin K|6-Epiophiobolin K

C25H36O3 (384.2664)

C23H44O4

C23H44O4 (384.3239)

Somalenone

C26H40O2 (384.3028)

(16S)-23,24,25,26,27-pentanorcycloartan-3-one-16,22-olide|(5alpha,16beta,20S)-23,24,25,26,27-Pentanor-3-oxocycloartan-22,16-olide

C25H36O3 (384.2664)

Tricosanedioic acid

C23H44O4 (384.3239)

3-(Dimethylamino)pregna-14,16-dien-20-yl(methyl)formamide

C25H40N2O (384.314)

cyclointeinone|cyclolinteinone

C25H36O3 (384.2664)

ceriferic acid-I methyl ester

C26H40O2 (384.3028)

Cochliobolin C|ophiobolin I

C25H36O3 (384.2664)

coniferylalcohol-4-O-farnesyl ether

C25H36O3 (384.2664)

C25H40N2O

C25H40N2O (384.314)

(20S)-3beta-N-methyl-20-(N-acetyl-N-methylamino)-pregna-5,14-diene

C25H40N2O (384.314)

(10S)-3c,8c,12c,14c,17c-Pentahydroxy-10r,13c-dimethyl-17t-((Xi)-1-hydroxy-aethyl)-(5tH,9tH)-hexadecahydro-1H-cyclopenta[a]phenanthren|(3?,5?,12?,14?,17S,20R)-Pregnane-3,8,12,14,17,20-hexol|3beta,8beta,12beta,14,17beta-Pentahydroxy-10,13-dimethyl-17alpha-((Xi)-1-hydroxy-aethyl)-5alpha,14beta-gonan|5alpha,14beta,17betaH-Pregnanhexol-(3beta,8,12beta,14,17,20xi)|5alpha-Dihydrosarcostin|diginanehexol-(3beta,8,12beta,14,17,20xi)|Diginanhexol-(3beta,8,12beta,14,17,20xi)|Dihydrosarcostin

C21H36O6 (384.2512)

12-deacetyl-18-epi-12-oxoscalaradial

C25H36O3 (384.2664)

sesqui-CBG|Sesquicannabigerol

C26H40O2 (384.3028)

(2R*,5S*,7S*,10S*)-10-methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol

C21H36O6 (384.2512)

3-oxo-choladien-(1.4)-oic acid-(24)-methyl ester|3-Oxo-choladien-(1.4)-saeure-(24)-methylester|choladiene-1,4 one-3 oate-24 de methyle|methyl 3-oxochola-1,4-dien-24-oate

C25H36O3 (384.2664)

santinol A2

C22H40O5 (384.2876)

hippospongide A

C25H36O3 (384.2664)

Ile-Arg-Pro|IRP

C17H32N6O4 (384.2485)

(3beta,22E)-3-Hydroxy-26,27-dinorcholesta-5,22-diene-7,24-dione

C25H36O3 (384.2664)

elasclepial

C25H36O3 (384.2664)

Muellitol

C21H36O6 (384.2512)

amphiasterin B5

C23H44O4 (384.3239)

25-deoxycacospongionolide B

C25H36O3 (384.2664)

9-Hydroxy-cis-12-octadecenoat|isoricinoleic acid

C22H44O3Si (384.306)

6-epi-3-anhydroophiobolin B

C25H36O3 (384.2664)

23,6alpha-epoxy-labd-8,13(14),17-trien-16(R),19-olide

C25H36O3 (384.2664)

ceriferic acid methyl ester

C26H40O2 (384.3028)

(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) heptanoate

C25H36O3 (384.2664)

8-deoxyophiobolin J

C25H36O3 (384.2664)

Luffariolide A

C25H36O3 (384.2664)

raoulic acid methyl ester

C26H40O2 (384.3028)

Me ester,di-Ac-(7S,8Z)-7,16-Dihydroxy-8-hexadecenoic acid

C21H36O6 (384.2512)

(23E)-3beta-hydroxy-27-norcholesta-5,23-dien-25-one

C26H40O2 (384.3028)

ACMC-20n2ye

C22H44O3Si (384.306)

7-oxo-chola-3,5-dien-24-oic acid methyl ester|7-Oxo-chola-3,5-dien-24-saeure-methylester|methyl 7-oxochola-3,5-dien-24-oate

C25H36O3 (384.2664)

Xestamine A

C25H40N2O (384.314)

Luffarin H

C25H36O3 (384.2664)

Ac,Et ester-20-Hydroxyeicosanoic acid

C23H44O4 (384.3239)

25-deoxycacospongionolide

C25H36O3 (384.2664)

prolylisoleucylarginine

C17H32N6O4 (384.2485)

L 759633

C26H40O2 (384.3028)

Oleoyl oxazolopyridine

C24H36N2O2 (384.2777)

isoleucylprolylarginine

C17H32N6O4 (384.2485)

17,20-dimethyl Prostaglandin F1α

C22H40O5 (384.2876)

Arg Pro Ile

C17H32N6O4 (384.2485)

Pro Arg Ile

C17H32N6O4 (384.2485)

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate

C21H36O6 (384.2512)

C23H32N2O3

C23H32N2O3 (384.2413)

C23H32N2O3

C23H32N2O3 (384.2413)

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate

C21H36O6 (384.2512)

MMV008439

C23H32N2O3 (384.2413)

Zipeprol

C23H32N2O3 (384.2413)

R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_99.4\\%

C21H36O6 (384.2512)

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_major

C21H36O6 (384.2512)

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_84.2\\%

C21H36O6 (384.2512)

Ala Pro Val Val

C18H32N4O5 (384.2373)

Ala Val Pro Val

C18H32N4O5 (384.2373)

Ala Val Val Pro

C18H32N4O5 (384.2373)

Gly Ile Pro Val

C18H32N4O5 (384.2373)

Gly Ile Val Pro

C18H32N4O5 (384.2373)

Gly Leu Pro Val

C18H32N4O5 (384.2373)

Gly Leu Val Pro

C18H32N4O5 (384.2373)

Gly Pro Ile Val

C18H32N4O5 (384.2373)

Gly Pro Leu Val

C18H32N4O5 (384.2373)

Gly Pro Val Ile

C18H32N4O5 (384.2373)

Gly Pro Val Leu

C18H32N4O5 (384.2373)

Gly Val Ile Pro

C18H32N4O5 (384.2373)

Gly Val Leu Pro

C18H32N4O5 (384.2373)

Gly Val Pro Ile

C18H32N4O5 (384.2373)

Gly Val Pro Leu

C18H32N4O5 (384.2373)

Leu Pro Arg

C17H32N6O4 (384.2485)

Ile Gly Pro Val

C18H32N4O5 (384.2373)

Ile Gly Val Pro

C18H32N4O5 (384.2373)

Ile Pro Gly Val

C18H32N4O5 (384.2373)

Ile Pro Val Gly

C18H32N4O5 (384.2373)

Ile Val Gly Pro

C18H32N4O5 (384.2373)

Ile Val Pro Gly

C18H32N4O5 (384.2373)

Arg Ile Pro

C17H32N6O4 (384.2485)

Leu Gly Pro Val

C18H32N4O5 (384.2373)

Leu Gly Val Pro

C18H32N4O5 (384.2373)

Ile Pro Arg

C17H32N6O4 (384.2485)

Pro Leu Arg

C17H32N6O4 (384.2485)

Leu Pro Gly Val

C18H32N4O5 (384.2373)

Leu Pro Val Gly

C18H32N4O5 (384.2373)

Leu Val Gly Pro

C18H32N4O5 (384.2373)

Leu Val Pro Gly

C18H32N4O5 (384.2373)

Pro Ala Val Val

C18H32N4O5 (384.2373)

Pro Gly Ile Val

C18H32N4O5 (384.2373)

Pro Gly Leu Val

C18H32N4O5 (384.2373)

Pro Gly Val Ile

C18H32N4O5 (384.2373)

Pro Gly Val Leu

C18H32N4O5 (384.2373)

Pro Ile Gly Val

C18H32N4O5 (384.2373)

Pro Ile Val Gly

C18H32N4O5 (384.2373)

Pro Leu Gly Val

C18H32N4O5 (384.2373)

Pro Leu Val Gly

C18H32N4O5 (384.2373)

Arg Leu Pro

C17H32N6O4 (384.2485)

Pro Val Ala Val

C18H32N4O5 (384.2373)

Pro Val Gly Ile

C18H32N4O5 (384.2373)

Pro Val Gly Leu

C18H32N4O5 (384.2373)

Pro Val Ile Gly

C18H32N4O5 (384.2373)

Pro Val Leu Gly

C18H32N4O5 (384.2373)

Pro Val Val Ala

C18H32N4O5 (384.2373)

Pro Arg Leu

C17H32N6O4 (384.2485)

Arg Pro Leu

C17H32N6O4 (384.2485)

Ile Arg Pro

C17H32N6O4 (384.2485)

Leu Arg Pro

C17H32N6O4 (384.2485)

Pro Ile Arg

C17H32N6O4 (384.2485)

Val Ala Pro Val

C18H32N4O5 (384.2373)

Val Ala Val Pro

C18H32N4O5 (384.2373)

Val Gly Ile Pro

C18H32N4O5 (384.2373)

Val Gly Leu Pro

C18H32N4O5 (384.2373)

Val Gly Pro Ile

C18H32N4O5 (384.2373)

Val Gly Pro Leu

C18H32N4O5 (384.2373)

Val Ile Gly Pro

C18H32N4O5 (384.2373)

Val Ile Pro Gly

C18H32N4O5 (384.2373)

Val Leu Gly Pro

C18H32N4O5 (384.2373)

Val Leu Pro Gly

C18H32N4O5 (384.2373)

Val Pro Ala Val

C18H32N4O5 (384.2373)

Val Pro Gly Ile

C18H32N4O5 (384.2373)

Val Pro Gly Leu

C18H32N4O5 (384.2373)

Val Pro Ile Gly

C18H32N4O5 (384.2373)

Val Pro Leu Gly

C18H32N4O5 (384.2373)

Val Pro Val Ala

C18H32N4O5 (384.2373)

Val Val Ala Pro

C18H32N4O5 (384.2373)

Val Val Pro Ala

C18H32N4O5 (384.2373)

9a-Fluoroallotetrahydrocortisol

C21H33FO5 (384.2312)

9a-Fluorotetrahydrocortisol

C21H33FO5 (384.2312)

L-759,633

C26H40O2 (384.3028)

17,20-dimethyl Prostaglandin F1&alpha

C22H40O5 (384.2876)

MG(20:1)

C23H44O4 (384.3239)

Kalkitoxin thioamide alcohol

C21H40N2O2S (384.281)

26:6(w3)

C26H40O2 (384.3028)

N-palmitoyl glutamine

C21H40N2O4 (384.2988)

(-)-Pyrifolidine

C23H32N2O3 (384.2413)

Persicaxanthin

C25H36O3 (384.2664)

Tetrahydropersin

C23H44O4 (384.3239)

Persicachrome

C25H36O3 (384.2664)

4,5-Dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenyl hexanoate

C21H36O6 (384.2512)

26:6n3

C26H40O2 (384.3028)

FA 23:1;O2

C23H44O4 (384.3239)

DICYCLOHEXYLAMINE (R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPROPANOATE

C21H40N2O4 (384.2988)

TRIMETHYL CIS,CIS-1,3,5-TRIPROPYL-1,3,5-CYCLOHEXANETRICARBOXYLATE

C21H36O6 (384.2512)

propylene glycol dicaprate

C23H44O4 (384.3239)

Boc-D-Abu-OH.DCHA

C21H40N2O4 (384.2988)

4,5-DIOCTYLOXY-1,2-BENZENEDICARBONITRILE

C24H36N2O2 (384.2777)

Pyrimidine, 2-[4-[1-(1-cyclohexyl-1H-tetrazol-5-yl)-3-methylbutyl]-1-piperazinyl]- (9CI)

C20H32N8 (384.275)

[2-(5-Carboxypentyl)-4,4-dimethyl-2-undecyl-1,3-oxazolidin-3-yl]o xidanyl

C22H42NO4 (384.3114)

heptanedioic acid, bis(2-ethylhexyl) ester

C23H44O4 (384.3239)

5-Doxyl stearic acid

C22H42NO4 (384.3114)

2,2-dimethylpropane-1,3-diyl dinonanoate

C23H44O4 (384.3239)

[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethylethyl ester

C23H32N2O3 (384.2413)

tert-butyl 4-(2-oxospiro[cyclohexane-1,3-indole]-1-yl)piperidine-1-carboxylate

C23H32N2O3 (384.2413)

12-Doxyl Stearic Acid

C22H42NO4 (384.3114)

butyl prop-2-enoate,6-methylheptyl prop-2-enoate,prop-2-enoic acid

C21H36O6 (384.2512)

Octaethylene glycol monomethyl ether

C17H36O9 (384.2359)

Diethyl hexadecylmalonate

C23H44O4 (384.3239)

3 6-DIOCTYLOXY-1 2-BENZENEDICARBONITRIL&

C24H36N2O2 (384.2777)

1-(2,6-Diisopropylphenyl)-3-(2,4,6-trimethylphenyl)-4,5-dihydroimidazolium chloride

C24H33ClN2 (384.2332)

Estradiol enanthate

C25H36O3 (384.2664)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen

MMB-CHMINACA

C23H32N2O3 (384.2413)

[4-(4-propylcyclohexyl)phenyl] 4-butylcyclohexane-1-carboxylate

C26H40O2 (384.3028)

MDMB-CHMICA

C23H32N2O3 (384.2413)

Estradiol 3-Enanthate

C25H36O3 (384.2664)

(2R)-2-cyclopentyl-2-hydroxy-N-[1-(4-methylpent-3-enyl)-4-piperidinyl]-2-phenylacetamide

C24H36N2O2 (384.2777)

(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclohexylpropanoyl)pyrrolidine-2-Carboxamide

C22H32N4O2 (384.2525)

Butyl [2-cyclohexyl-6-(pyrrolidin-1-yl)-1H-benzimidazol-5-yl]carbamate

C22H32N4O2 (384.2525)

4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene

C22H32N4O2 (384.2525)

[3-carboxy-2-[(E)-pentadec-9-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)

(Z)-3-(1,2-Dihydroxyethyl)-3-hydroxyhenicos-12-en-2-one

C23H44O4 (384.3239)

4-(4,4-Dimethyl-3-oxido-2-tridecyl-1,3-oxazolidin-2-yl)butanoic acid

C22H42NO4- (384.3114)

[3-carboxy-2-[(5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[(2R)-3-carboxy-2-[(3R,5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(8E,11E)-6-hydroxytetradeca-8,11-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(9E,11E)-7-hydroxytetradeca-9,11-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(8E,10E)-6-hydroxytetradeca-8,10-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(7E,9E)-5-hydroxytetradeca-7,9-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(8E,11E)-5-hydroxytetradeca-8,11-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(6E,8E)-4-hydroxytetradeca-6,8-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(6E,9E)-3-hydroxytetradeca-6,9-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(7E,10E)-4-hydroxytetradeca-7,10-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(10E,12E)-4-hydroxytetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(9E,12E)-6-hydroxytetradeca-9,12-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(10E,12E)-8-hydroxytetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(5E,7E)-3-hydroxytetradeca-5,7-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(4E,6E)-2-hydroxytetradeca-4,6-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

[3-carboxy-2-[(E)-pentadec-10-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)

[3-carboxy-2-[(E)-pentadec-2-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)

[3-carboxy-2-[(E)-pentadec-7-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)

[3-carboxy-2-[(E)-pentadec-6-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)

[3-carboxy-2-[(E)-pentadec-5-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)

(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene

C26H40O2 (384.3028)

Sesquicannabigerol

C26H40O2 (384.3028)

A natural product found in Cannabis sativa.

2,3-Dihydroxypropyl (11Z)-icos-11-enoate

C23H44O4 (384.3239)

17,20-dimethyl Prostaglandin F1alpha

C22H40O5 (384.2876)

Leu-Pro-Arg

C17H32N6O4 (384.2485)

Pro-Leu-Arg

C17H32N6O4 (384.2485)

rel-(2R,5S,7S,10S)-10-Methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol

C21H36O6 (384.2512)

A natural product found in Carthamus oxyacantha and Carduncellus mareoticus.

2,3-Dihydroxypropyl icos-11-enoate

C23H44O4 (384.3239)

Leu-Arg-Pro

C17H32N6O4 (384.2485)

Arg-Pro-Ile

C17H32N6O4 (384.2485)

Pro-Arg-Leu

C17H32N6O4 (384.2485)

Ile-Arg-Pro

C17H32N6O4 (384.2485)

Ile-Pro-Arg

C17H32N6O4 (384.2485)

Arg-Ile-Pro

C17H32N6O4 (384.2485)

Arg-Pro-Leu

C17H32N6O4 (384.2485)

N-tert-butyl-2-[2-ethoxy-4-[(2-phenylethylamino)methyl]phenoxy]acetamide

C23H32N2O3 (384.2413)

N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide

C23H32N2O3 (384.2413)

N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide

C23H32N2O3 (384.2413)

2-cyclopropyl-1-[(2R,3S)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone

C23H32N2O3 (384.2413)

Tandospirone cation

C21H30N5O2+ (384.2399)

Arg-Leu-Pro

C17H32N6O4 (384.2485)

Pro-Ile-Arg

C17H32N6O4 (384.2485)

Pro-Arg-Ile

C17H32N6O4 (384.2485)

dihydrostemphyloxin I

C21H36O6 (384.2512)

An octahydronaphthalene that is stemphyloxin I in which the C=C bond of the enol moiety has been reduced to a C-C bond.

2-[2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethyl]-N,N,1-trimethylquinolin-1-ium-6-amine

C26H30N3+ (384.244)

[(1S)-3-carboxy-1-[(5E,7E)-3-hydroxytetradeca-5,7-dienoyl]oxypropyl]-trimethylazanium

C21H38NO5+ (384.275)

1-Oleyl-2-acetyl-glycerol

C23H44O4 (384.3239)

(2R)-1-(dimethylamino)-2-[4-[(4-methoxy-3-methylphenyl)methyl]-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]propan-2-ol

C23H32N2O3 (384.2413)

Undecanedioic acid dihexyl ester

C23H44O4 (384.3239)

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] propanoate

C23H44O4 (384.3239)

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] pentanoate

C23H44O4 (384.3239)

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] hexanoate

C23H44O4 (384.3239)

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] heptanoate

C23H44O4 (384.3239)

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] butanoate

C23H44O4 (384.3239)

Fahfa 7:0/16:0

C23H44O4 (384.3239)

Fahfa 20:0/3:0

C23H44O4 (384.3239)

Fahfa 3:0/20:0

C23H44O4 (384.3239)

Fahfa 17:0/6:0

C23H44O4 (384.3239)

Fahfa 14:0/9:0

C23H44O4 (384.3239)

Fahfa 5:0/18:0

C23H44O4 (384.3239)

Fahfa 18:0/5:0

C23H44O4 (384.3239)

Fahfa 4:0/19:0

C23H44O4 (384.3239)

Fahfa 15:0/8:0

C23H44O4 (384.3239)

Fahfa 19:0/4:0

C23H44O4 (384.3239)

Fahfa 9:0/14:0

C23H44O4 (384.3239)

Fahfa 6:0/17:0

C23H44O4 (384.3239)

Fahfa 8:0/15:0

C23H44O4 (384.3239)

Fahfa 16:0/7:0

C23H44O4 (384.3239)

Fahfa 2:0/21:0

C23H44O4 (384.3239)

Fahfa 12:0/11:0

C23H44O4 (384.3239)

Fahfa 11:0/12:0

C23H44O4 (384.3239)

Fahfa 13:0/10:0

C23H44O4 (384.3239)

Fahfa 10:0/13:0

C23H44O4 (384.3239)

2-Henicosanoyloxyacetic acid

C23H44O4 (384.3239)

(1-hexanoyloxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate

C22H40O5 (384.2876)

(1-hydroxy-3-pentanoyloxypropan-2-yl) (Z)-tetradec-9-enoate

C22H40O5 (384.2876)

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-heptadec-9-enoate

C22H40O5 (384.2876)

(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-hexadec-9-enoate

C22H40O5 (384.2876)

(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-pentadec-9-enoate

C22H40O5 (384.2876)

[(2S)-2,3-dihydroxypropyl] (E)-icos-11-enoate

C23H44O4 (384.3239)

[(2S)-2,3-dihydroxypropyl] (E)-icos-13-enoate

C23H44O4 (384.3239)

2-[Hydroxy-(2-hydroxy-3-nonoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C17H39NO6P+ (384.2515)

Ibutilide

C20H36N2O3S (384.2447)

C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker

8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid

C26H40O2 (384.3028)

A very long-chain omega-3 fatty acid that is hexacosanoic acid having six double bonds located at positions 8, 11, 14, 17, 20, 23 (the 8Z,11Z,14Z,17Z,20Z,23Z-isomer).

2-eicosenoyl-glycerol

C23H44O4 (384.3239)

16-Nitroxystearate

C22H42NO4 (384.3114)

Hydroxypentacosaheptaenoic acid

C25H36O3 (384.2664)

Hexacosahexaenoic acid

C26H40O2 (384.3028)

NA-Arg 15:0

C20H40N4O3 (384.31)

NA-Asn 17:0

C21H40N2O4 (384.2988)

NA-Gln 16:0

C21H40N2O4 (384.2988)

NA-Tryptamine 15:0

C25H40N2O (384.314)

FAHFA 10:0/3O-13:0

C23H44O4 (384.3239)

FAHFA 10:0/O-13:0

C23H44O4 (384.3239)

FAHFA 11:0/3O-12:0

C23H44O4 (384.3239)

FAHFA 11:0/O-12:0

C23H44O4 (384.3239)

FAHFA 12:0/3O-11:0

C23H44O4 (384.3239)

FAHFA 12:0/O-11:0

C23H44O4 (384.3239)

FAHFA 13:0/3O-10:0

C23H44O4 (384.3239)

FAHFA 13:0/O-10:0

C23H44O4 (384.3239)

FAHFA 14:0/3O-9:0

C23H44O4 (384.3239)

FAHFA 14:0/O-9:0

C23H44O4 (384.3239)

FAHFA 15:0/3O-8:0

C23H44O4 (384.3239)

FAHFA 15:0/O-8:0

C23H44O4 (384.3239)

FAHFA 17:0/3O-6:0

C23H44O4 (384.3239)

FAHFA 23:0;O

C23H44O4 (384.3239)

FAHFA 5:0/12O-18:0

C23H44O4 (384.3239)

FAHFA 7:0/3O-16:0

C23H44O4 (384.3239)

FAHFA 8:0/15O-15:0

C23H44O4 (384.3239)

FAHFA 8:0/O-15:0

C23H44O4 (384.3239)

FAHFA 9:0/2O-14:0

C23H44O4 (384.3239)

FAHFA 9:0/O-14:0

C23H44O4 (384.3239)

MG 20:1

C23H44O4 (384.3239)

ST 21:0;O6

C21H36O6 (384.2512)

ST 21:0;O;S

C21H36O4S (384.2334)

ST 25:4;O3

C25H36O3 (384.2664)

ST 26:3;O2

C26H40O2 (384.3028)

(2s,3r,4r,4as,5r,7r,8as)-3-[(2r)-butan-2-yl]-2,7-dihydroxy-7-(hydroxymethyl)-4-(3-hydroxypropanoyl)-2,4,5-trimethyl-hexahydronaphthalen-1-one

C21H36O6 (384.2512)

(1r,3s,4r,7s,8e,11s,12r)-4-hydroxy-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde

C25H36O3 (384.2664)

4-[5-(2-{1a,5,6-trimethyl-octahydrocyclopropa[e]naphthalen-5-yl}ethyl)-3,6-dihydro-2h-pyran-2-yl]-5h-furan-2-one

C25H36O3 (384.2664)

(1s,3r,6s,9s,10s,11s,13e,17r,19s,20r)-17-hydroxy-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-15-one

C25H36O3 (384.2664)

4-[6-(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)-4-methylhexa-1,3-dien-1-yl]-5-hydroxy-5h-furan-2-one

C25H36O3 (384.2664)

(3s,5s)-5-(hydroxymethyl)-3-[(15e)-icosa-15,19-dien-11,13-diyn-1-yl]oxolan-2-one

C25H36O3 (384.2664)

3-{7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}butanal

C26H40O2 (384.3028)

3-[(3e,7e)-4,8-dimethyl-10-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

13-hydroxy-5b,8,8,11a,13a-pentamethyl-5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4-one

C25H36O3 (384.2664)

(1r,3s,4r,7s,11s)-4-hydroxy-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde

C25H36O3 (384.2664)

(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r,3e)-5-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H40O2 (384.3028)

(1r,3s,4r,7r,11s)-4-hydroxy-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde

C25H36O3 (384.2664)

2-{2-[(1r,3ar,4e,7ar)-1,6,6-trimethyl-hexahydro-1h-inden-4-ylidene]propoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H36O6 (384.2512)

2-(hydroxymethyl)-6-[(3,7,11-trimethyldodeca-1,6,10-trien-3-yl)oxy]oxane-3,4,5-triol

C21H36O6 (384.2512)

(1r,2r,3r,4r,5r,6r)-1,3,5-tris(3-methylbut-2-en-1-yl)cyclohexane-1,2,3,4,5,6-hexol

C21H36O6 (384.2512)

2-(hydroxymethyl)-6-[(4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl)oxy]oxane-3,4,5-triol

C21H36O6 (384.2512)

(2e)-3-(3-methoxy-4-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}phenyl)prop-2-en-1-ol

C25H36O3 (384.2664)

4-[(1e,3e)-4-{2-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl}-5-hydroxypenta-1,3-dien-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

methyl 2-[(1s,4s,6r,10r,12r)-1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoate

C26H40O2 (384.3028)

methyl (1e,4r,7e,11e)-7,11-dimethyl-4-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)

1,2-dimethyl-4-(12-phenyldodecyl)cyclohexa-3,5-diene-1,2-diol

C26H40O2 (384.3028)

4-[(3e,7e)-4,8-dimethyl-10-[(1r,6r)-1,2,6-trimethyl-4-oxocyclohex-2-en-1-yl]deca-3,7-dien-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

(1r,4r,5r,9s,10s,13r,16s)-5-formyl-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl (2z)-2-methylbut-2-enoate

C25H36O3 (384.2664)

(1s,3r,6s,9s,10r,11s,13e,17r,19s,20r)-17-hydroxy-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-15-one

C25H36O3 (384.2664)

(6s)-3-methyl-6-[(2s,5r)-6-methyl-5-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}heptan-2-yl]cyclohex-2-en-1-one

C21H36O6 (384.2512)

6-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}hept-3-en-2-one

C26H40O2 (384.3028)

5-formyl-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl 2-methylbut-2-enoate

C25H36O3 (384.2664)

(1's,2s,3s,3'r,5r,7'r,9'e,11's)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

1,2-dimethyl-5-(12-phenyldodecyl)cyclohexa-3,5-diene-1,3-diol

C26H40O2 (384.3028)

12-hydroxy-1,4-dimethyl-12-(6-methylhept-5-en-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H36O3 (384.2664)

(1r,3as,4s,5r,7ar)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2s,3e)-5-methylhex-3-en-2-yl]-octahydroinden-5-ol

C26H40O2 (384.3028)

9a,11a-dimethyl-1-(5-methylhexan-2-yl)-1h,2h,3h,3ah,3bh,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-dione

C26H40O2 (384.3028)

(5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4-one

C25H36O3 (384.2664)

methyl 5,11-dimethyl-8-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,11-triene-1-carboxylate

C26H40O2 (384.3028)

methyl 2-[(1s,3s,4r,7e,11r,12s)-3,4,11,12-tetrahydroxy-4,8,12-trimethylcyclotetradec-7-en-1-yl]prop-2-enoate

C21H36O6 (384.2512)

(1r,4r,5r,9s,10s,13r,16s)-5-formyl-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl (2e)-2-methylbut-2-enoate

C25H36O3 (384.2664)

(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C26H40O2 (384.3028)

4-[(1e)-2-(1,2,4a,8,8-pentamethyl-3,4,4b,5,6,7,10,10a-octahydro-2h-phenanthren-1-yl)ethenyl]-5-hydroxy-5h-furan-2-one

C25H36O3 (384.2664)

(6r)-6-[(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]hept-1-en-3-one

C26H40O2 (384.3028)

(2s,3r,4r,5r,6r)-2-(hydroxymethyl)-6-{[(3s)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxane-3,4,5-triol

C21H36O6 (384.2512)

(1s,3r,6r,7s,13s,15r,16s)-15-hydroxy-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-en-11-one

C25H36O3 (384.2664)

(1'r,2s,3s,3'r,5r,7'r,10'z)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-10',13'-dien-12'-one

C25H36O3 (384.2664)

(1's,2s,3s,3'r,5r,7'r,11'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

methyl 7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)

5-(hydroxymethyl)-3-(icosa-15,19-dien-11,13-diyn-1-yl)oxolan-2-one

C25H36O3 (384.2664)

(5z)-5-[(2e)-3-{2-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl}-4-hydroxybut-2-en-1-ylidene]-4-methylfuran-2-one

C25H36O3 (384.2664)

n-{1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalen-7-yl}-n'-(2-phenylethyl)carbamimidothioic acid

C24H36N2S (384.2599)

methyl 7,11-dimethyl-4-(6-methylhepta-2,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)

methoxy(methyl)[(11z)-18-(pyridin-3-yl)octadec-11-en-13-yn-1-yl]amine

C25H40N2O (384.314)

4b,7,7,10a,12a-pentamethyl-12-oxo-4,4a,5,6,6a,8,9,10,10b,11-decahydro-1h-chrysene-1,2-dicarbaldehyde

C25H36O3 (384.2664)

4-[(1e)-4-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-5-hydroxypenta-1,3-dien-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

n-[2-(1h-indol-3-yl)ethyl]pentadecanimidic acid

C25H40N2O (384.314)

(8z)-20-(5-formyl-1h-pyrrol-2-yl)icos-8-enenitrile

C25H40N2O (384.314)

n-[(1s)-1-[(1s,3br,7s,9ar,9bs,11ar)-9a,11a-dimethyl-7-(methylamino)-1h,2h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

C25H40N2O (384.314)

2,16-dimethyl-15-(5-methylhex-3-en-2-yl)-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-10-en-5-ol

C26H40O2 (384.3028)

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-5-methylhexan-2-yl]-1h,2h,3h,3ah,3bh,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-dione

C26H40O2 (384.3028)

(3s,4s,5r)-5-heptadecyl-4-hydroxy-3-(hydroxymethyl)-5-methyloxolan-2-one

C23H44O4 (384.3239)

2-({2-[(5s,7r,10s)-7-hydroxy-10-methyl-6-methylidenespiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O6 (384.2512)

methyl (1e,4r,7e,11e)-7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)

6-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}hept-1-en-3-one

C26H40O2 (384.3028)

5-heptadecyl-4-hydroxy-3-(hydroxymethyl)-5-methyloxolan-2-one

C23H44O4 (384.3239)

2-(14-carboxytetradecyl)-4-methyl-5-oxooxolane-3-carboxylic acid

C21H36O6 (384.2512)

11-hydroxy-1,4,8,12,17-pentamethyl-19-oxatricyclo[13.6.0.0¹⁶,²⁰]henicosa-3,7,12,16(20)-tetraen-21-one

C25H36O3 (384.2664)

2,7-dihydroxy-7-(hydroxymethyl)-4-(3-hydroxypropanoyl)-2,4,5-trimethyl-3-(sec-butyl)-hexahydronaphthalen-1-one

C21H36O6 (384.2512)

7-hydroxy-9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C26H40O2 (384.3028)

5-(3-hydroxy-2-methylprop-1-en-1-yl)-3,3',10',14'-tetramethylspiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-10',13'-dien-12'-one

C25H36O3 (384.2664)

4-hydroxy-1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde

C25H36O3 (384.2664)

4-[(2s)-5-{2-[(1r,2r,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5h-furan-2-one

C25H36O3 (384.2664)

3-[4,8-dimethyl-10-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

4-[(3e)-4-methyl-6-[(1r,2r,3s,6r,10s)-3,6,7,10-tetramethyl-9-oxotricyclo[4.3.1.0³,¹⁰]decan-2-yl]hex-3-en-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

n-[(1as,4s,4as,7s,7as,7br)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]-n'-(2-phenylethyl)carbamimidothioic acid

C24H36N2S (384.2599)

15-hydroxy-3,15-dimethyl-6-(6-methylhepta-3,5-dien-2-yl)-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-en-11-one

C25H36O3 (384.2664)

4-{5-[2-(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)ethyl]-3,6-dihydro-2h-pyran-2-yl}-5h-furan-2-one

C25H36O3 (384.2664)

(1s,2r,5s,7r,9s,12r,15r,16r)-2,16-dimethyl-15-[(2r,3e)-5-methylhex-3-en-2-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-10-en-5-ol

C26H40O2 (384.3028)

(1r,3s,7r,8e,11r,12s)-12-hydroxy-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H36O3 (384.2664)

4-[(1e,3z)-5-hydroxy-4-[(3e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]penta-1,3-dien-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

4-{4-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-5-hydroxypenta-1,3-dien-1-yl}-5h-furan-2-one

C25H36O3 (384.2664)

1-(5-hydroxy-5-methylhex-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H40O2 (384.3028)

(1s,4as,4br,6as,10as,10br,12as)-4b,7,7,10a,12a-pentamethyl-12-oxo-4,4a,5,6,6a,8,9,10,10b,11-decahydro-1h-chrysene-1,2-dicarbaldehyde

C25H36O3 (384.2664)

4-[(2s)-5-{2-[(1as,4ar,5s,6s,8as)-1a,5,6-trimethyl-octahydrocyclopropa[e]naphthalen-5-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5h-furan-2-one

C25H36O3 (384.2664)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1r,2e,4s,7e)-4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl]oxy}oxane-3,4,5-triol

C21H36O6 (384.2512)

(1's,2s,3s,3'r,5r,7'r,11'r)-14'-(hydroxymethyl)-3,3',10'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

14'-(hydroxymethyl)-3,3',10'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

(2s,3r,4s,5r,6r)-2-({2-[(2r,5r,7r,10r)-7-hydroxy-10-methyl-6-methylidenespiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O6 (384.2512)

4-[(1z,3e)-4-{2-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl}-5-hydroxypenta-1,3-dien-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

(5z)-5-{3-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-4-hydroxybut-2-en-1-ylidene}-4-methylfuran-2-one

C25H36O3 (384.2664)

4-[(3e)-4-methyl-6-[(1r,2r,3s,6r,7r,10s)-3,6,7,10-tetramethyl-9-oxotricyclo[4.3.1.0³,¹⁰]decan-2-yl]hex-3-en-1-yl]-5h-furan-2-one

C25H36O3 (384.2664)

(1r,3e,7z,12e,15s,17r)-11-hydroxy-1,4,8,12,17-pentamethyl-19-oxatricyclo[13.6.0.0¹⁶,²⁰]henicosa-3,7,12,16(20)-tetraen-21-one

C25H36O3 (384.2664)

(1's,2s,3s,3'r,5r,7'r,9'e,11'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

(1's,2s,3s,3'r,5r,7'r,11'r)-5-(3-hydroxy-2-methylprop-1-en-1-yl)-3,3',10',14'-tetramethylspiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

(1s,4r,5r,6s,9s,11s,12s,15r,20r)-4,6,11,16,16-pentamethyl-8-oxahexacyclo[10.9.0.0¹,²⁰.0⁴,¹¹.0⁵,⁹.0¹⁵,²⁰]henicosane-7,17-dione

C25H36O3 (384.2664)

(2s,3s,3'r,5r,7'r,9'e,14'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-1'(11'),9'-dien-12'-one

C25H36O3 (384.2664)

(1s,3r,6s,9s,10r,11s,17r,19s,20r)-17-hydroxy-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-15-one

C25H36O3 (384.2664)

(1r,4r,4ar,5r,8as)-4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1h-naphthalen-1-yl hexanoate

C21H36O6 (384.2512)

methyl 5,9-dimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene-1-carboxylate

C26H40O2 (384.3028)

(1r,3as,4s,5r,7ar)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-octahydroinden-5-ol

C26H40O2 (384.3028)

17-hydroxy-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-15-one

C25H36O3 (384.2664)

n-{1-[9a,11a-dimethyl-7-(methylamino)-1h,2h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl}-n-methylacetamide

C25H40N2O (384.314)

3-{3-methoxy-4-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]phenyl}prop-2-en-1-ol

C25H36O3 (384.2664)

(3e,6r)-6-[(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]hept-3-en-2-one

C26H40O2 (384.3028)

2-(1-hydroxy-13-phenyltridecylidene)cyclohexane-1,3-dione

C25H36O3 (384.2664)

4,6,11,16,16-pentamethyl-8-oxahexacyclo[10.9.0.0¹,²⁰.0⁴,¹¹.0⁵,⁹.0¹⁵,²⁰]henicosane-7,17-dione

C25H36O3 (384.2664)

n'-(2-phenylethyl)-n-{1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl}carbamimidothioic acid

C24H36N2S (384.2599)

(1r,3s,4r,7r,8e,11s,12r)-4-hydroxy-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde

C25H36O3 (384.2664)

(3r)-3-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]butanal

C26H40O2 (384.3028)

methyl (1e,5z,9e,12r)-5,9-dimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene-1-carboxylate

C26H40O2 (384.3028)

n-[(1ar,3as,7s,7as,7br)-1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalen-7-yl]-n'-(2-phenylethyl)carbamimidothioic acid

C24H36N2S (384.2599)

(3s,5s)-5-(hydroxymethyl)-3-[(15z)-icosa-15,19-dien-11,13-diyn-1-yl]oxolan-2-one

C25H36O3 (384.2664)

1-{12-ethyl-5,6-dimethoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-8-yl}ethanone

C23H32N2O3 (384.2413)

3-hydroxy-2-(13-phenyltridecanoyl)cyclohex-2-en-1-one

C25H36O3 (384.2664)

5-pentyl-2-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol

C26H40O2 (384.3028)

10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-12'-one

C25H36O3 (384.2664)

21-(furan-2-yl)henicosa-5,7-diynoic acid

C25H36O3 (384.2664)

methyl (1z,5e,8r,11e)-5,11-dimethyl-8-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,11-triene-1-carboxylate

C26H40O2 (384.3028)

2-({2-[(5s,7s,10s)-7-hydroxy-10-methyl-6-methylidenespiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O6 (384.2512)

methyl 2-[1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoate

C26H40O2 (384.3028)

1-(acetyloxy)-3-(5-decyl-2-oxooxolan-3-yl)propan-2-yl acetate

C21H36O6 (384.2512)

(5s)-4-[(1e,3e)-6-[(1r,2s,4ar,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]-4-methylhexa-1,3-dien-1-yl]-5-hydroxy-5h-furan-2-one

C25H36O3 (384.2664)

5-decyl-3-(2,3-diisopropoxypropyl)oxolan-2-one

C23H44O4 (384.3239)

1,3,5-tris(3-methylbut-2-en-1-yl)cyclohexane-1,2,3,4,5,6-hexol

C21H36O6 (384.2512)

(5r)-4-[(1e)-2-[(1r,4as,4bs,8as,10as)-4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl]ethenyl]-5-hydroxy-5h-furan-2-one

C25H36O3 (384.2664)